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Pathogenically diverse Chlamydia spp. can have surprisingly similar genomes. Chlamydia trachomatis isolates that cause tra-
choma, sexually transmitted genital tract infections (chlamydia), and invasive lymphogranuloma venereum (LGV) and the mu-
rine strain Chlamydia muridarum share 99% of their gene content. A region of high genomic diversity between Chlamydia spp.
termed the plasticity zone (PZ) may encode niche-specific virulence determinants that dictate pathogenic diversity. We hypothe-
sized that PZ genes might mediate the greater virulence and gamma interferon (IFN-) resistance of C. muridarum compared to
C. trachomatis in the murine genital tract. To test this hypothesis, we isolated and characterized a series of C. muridarum PZ
nonsense mutants. Strains with nonsense mutations in chlamydial cytotoxins, guaBA-add, and a phospholipase D homolog de-
veloped normally in cell culture. Two of the cytotoxin mutants were less cytotoxic than the wild type, suggesting that the cyto-
toxins may be functional. However, none of the PZ nonsense mutants exhibited increased IFN- sensitivity in cell culture or
were profoundly attenuated in a murine genital tract infection model. Our results suggest that C. muridarum PZ genes are tran-
scribed—and somemay produce functional proteins—but are dispensable for infection of the murine genital tract.
Acquisition of genetic islands encoding the machinery neces-sary to invade eukaryotic cells was a key event in the evolution
of many bacterial pathogens from free-living ancestors. For those
pathogens that subsequently lost the ability to replicate outside
host cells, a dearth of foreign microbial genetic material and
Muller’s ratchet may have tilted the balance of niche adaptation
toward genomic decay. Reductive evolution appears to have
played an especially pivotal role in niche adaptation of the obligate
intracellular bacterial pathogens in the family Chlamydiaceae (1).
Understanding why extant Chlamydia spp. retained different
combinations of the metabolic pathways encoded by their com-
mon ancestors could reveal insights into chlamydial pathogenesis
and cognate immune defenses against these intracellular patho-
gens.
Whole-genome comparisons provided early clues concerning
the importance of genomic streamlining in chlamydial evolution
but less insight into how loss of specific genes and metabolic path-
ways is adaptive (2–5). What is clear is that the genomes of patho-
genically diverse Chlamydia spp. are small, have limited biosyn-
thetic capacity, and are remarkably similar. For example, the
murine pathogen Chlamydia muridarum and pathogenically di-
verse Chlamydia trachomatis isolates share 99% of their gene con-
tent (4). Various hypotheses have been put forth to explain this
paradox, which was recently described as “divergence without dif-
ference” (6). One idea is that polymorphisms in conserved genes
are key chlamydial virulence determinants. Some C. trachomatis
trachoma strains have no obvious novel genes that differentiate
them from genital strains (7), and some trachoma strains that vary
in sensitivity to gamma interferon (IFN-) differ by only a few
polymorphisms in conserved “core” genes (8). Alternatively, but
not exclusively, open reading frames (ORFs) that have accumu-
lated in a variable genomic region termed the plasticity zone (PZ)
may be determinants of chlamydial pathogenic diversity (4).
Comparative genomic and biochemical studies have implied that
a partial tryptophan operon in the PZs of some C. trachomatis
strains could reflect niche adaptation to immune-regulated tryp-
tophan availability (9–12). Functionality of chlamydial trypto-
phan synthase, the product of this operon, in cell culture was
recently confirmed using a reverse genetic strategy (13). Whether
other PZ ORFs similarly mediate chlamydial niche adaptation or
the PZ primarily houses inactive and decaying genes remains un-
clear.
The PZ is consistently located near the region of replication
termination in Chlamydia spp. but varies considerably in size and
gene content (4). Some PZ ORFs have no homologs outside Chla-
mydia, whereas others have been grouped into families based
upon the homology of their predicted protein products to char-
acterized bacterial and mammalian proteins. Some Chlamydia
spp. encode a protein that resembles eukaryotic membrane attack
complex (MAC) proteins and perforin (MACPF) in the PZ (4,
14). Various functions have been ascribed to chlamydial MACPFs,
including immune evasion by molecular mimicry, protein secre-
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tion, and bacterial entry/exit (14, 15). Chlamydial MACPF is also
purported to assist in lipid modification because of its proximity
to a cluster of phospholipase D (PLD)-like genes (14, 16). Indirect
evidence also suggests that PZ PLDs, like their mammalian ho-
mologs, are sensitive to primary alcohols and play roles in lipid
acquisition or transfer (17, 18). The C. muridarum PZ contains
three putative cytotoxins that have similarity to the large clostrid-
ial toxins (LCTs) and yersinial YopT (4). The cytotoxin ORFs of C.
trachomatis serovars are truncated, disrupted, or absent altogether
(2, 19, 20). A guaBA-add operon found in C. muridarum, but not
C. trachomatis, could render the mouse pathogen less dependent
on host nucleotides (4). These purine interconversion genes are
replaced by trpRBA in C. trachomatis (2, 4). Limitations of avail-
able animal models and a historic lack of genetic tools have pre-
vented the testing of hypotheses concerning the functions of PZ
ORFs in chlamydial virulence and tropism. However, recent
breakthroughs in genetic manipulation of Chlamydia now make it
possible to address some of these questions directly (13, 21, 22).
Determining the functions of PZ ORFs could provide insight
into the molecular basis of chlamydial host and tissue tropism and
direct the design of improved animal models of human chlamyd-
ial disease. C. muridarum infection of the murine genital tract
(GT) is a leading model for the study of adaptive immunity to
genital infection because innate immunity is sufficient to clear
murine genital infection with human strains of C. trachomatis
(23). We and others have speculated that C. muridarum PZ genes
play roles analogous to that of C. trachomatis tryptophan synthase
in the circumvention of niche-specific innate immune responses
(4, 24). If correct, this also implies that specific effectors were
retained by C. muridarum because the cognate targets are relevant
barriers during the natural course of infection. Murine modeling
of C. trachomatis human urogenital tract infection might be im-
proved by use of C. muridarum PZ-null mutants and mice lacking
the corresponding targets of these effectors (25). Alternatively, if
PZ ORFs are dispensable for GT infection, it would suggest either
that these ORFs do not encode functional proteins or that the
appropriate targets of the proteins are not relevant during exper-
imental GT infection.
In this study, we used a combination of transcriptional profil-
ing, reverse genetic analysis, and mouse modeling to assess if C.
muridarum PZ ORFs are expressed and necessary for murine GT
infection. Our results suggest that although PZ ORFs are tran-
scribed, they are dispensable for infection of the murine GT.
MATERIALS AND METHODS
Cell lines, chlamydial culture, and infection. C. muridarum and C. tra-
chomatis serovar L2 strain 434/Bu (C. trachomatis) were kind gifts from
Harlan Caldwell (Rocky Mountain Laboratories, NIAID, Hamilton, MT).
Chlamydia organisms were routinely propagated in McCoy mouse fibro-
blast cells (American Type Culture Collection CRL-1696), and infectious
elementary bodies (EB) were purified by density gradient centrifugation
(26). McCoy cells and HeLa human cervical epithelial cells (American
Type Culture Collection CCL-2) were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) containing high-glucose HEPES, glutamine,
and sodium pyruvate (HyClone) and supplemented with 10% fetal bo-
vine serum albumin (Atlanta Biologicals) and 100 M nonessential
amino acids (Gibco). Infections were performed in tissue culture flasks or
plates with appropriate dilutions of chlamydial stock in SPG buffer (0.25
M sucrose, 10 mmol/liter phosphate, 5 mmol/liter L-glutamic acid, pH
7.2). The infected flasks were rocked for 2 h at 37°C, whereas infected
plates were centrifuged at room temperature for 1 h, followed by rocking
at 37°C for 30 min. During large-scale propagation experiments, SPG was
replaced with fresh DMEM containing 0.5g/ml cycloheximide. In some
experiments, DMEM containing 20 U/ml murine IFN- (R&D Systems)
was added to McCoy cells 24 h prior to infection and postinfection. Cy-
cloheximide was excluded from the cell culture media in experiments
where IFN- was added.
Recoverable IFU (rIFU) assays. McCoy cells in 24-well plates were
infected with C. muridarum or PZ mutants at a multiplicity of infection
(MOI) of 0.25. The infected cell monolayers were frozen in 500 l SPG at
various intervals postinfection (p.i.). Upon thawing, cells were scraped
using a pipette tip and EB were harvested by bead beating the cell suspen-
sion in microcentrifuge tubes. Inclusion-forming unit (IFU) assays were
performed using serial dilutions of the harvests to infect confluent McCoy
cell monolayers in 96-well plates. Cells were fixed with methanol and
stained with anti-chlamydial lipopolysaccharide (LPS) monoclonal anti-
body (MAb) (EVIH1), followed by a secondary Alexa Fluor 488-conju-
gated anti-mouse IgG MAb (Life Technologies) at 24 h p.i. Chlamydial
inclusions were imaged and enumerated using an EVOS FL Auto cell-
imaging system (Life Technologies).
RT-PCR and qRT-PCR. McCoy cells in six-well plates were infected
with C. muridarum at an MOI of 1. Total RNA was extracted at 0, 6, 12, 18,
24, and 30 h p.i. using TriSure reagent (Bioline), treated with DNase I
(Qiagen) for 15 min, and then purified on GeneJet RNA purification
columns (Thermo Scientific). Reverse transcriptase (RT) PCRs were per-
formed using 100 ng of total RNA and gene-specific primers (see Table S1
in the supplemental material) or primer pairs spanning intergenic regions
(see Table S3 in the supplemental material) using the MyTaq one-step
RT-PCR kit (Bioline). For quantitative RT-PCR (qRT-PCR) experiments,
total RNA was converted to cDNA using the Maxima H Minus first-strand
cDNA synthesis kit (Thermo Scientific). The qRT-PCRs were performed
in an Eppendorf Realplex4 thermocycler using SensiFast SYBR No-Rox
master mix (Bioline) with gene-specific primers (see Table S2 in the sup-
plemental material). The amplification cycle included a 2-min step at
95°C, followed by 40 cycles of 95°C for 5 s, 60°C for 10 s, and 72°C for
20 s. Absolute transcript copy numbers were calculated by normalizing to
standard curves of C. muridarum genomic DNA amplified in parallel with
experimental samples. Control reaction mixtures lacking RT were run in
parallel with all RT-PCR and qRT-PCR experiments.
PZcloning and-galactosidase assays.Overlapping 500- to 1,000-bp
regions of the C. muridarum PZ were PCR amplified from C. muridarum
genomic DNA and were cloned upstream of the lacZ gene in pAC-lacZ
between the NruI and EagI sites of the vector (27). The sequences of the
PCR primers and the genomic coordinates of the cloned PZ regions are
listed in Table S4 in the supplemental material. The resulting plasmids
were transformed into Escherichia coli DH5, and the inserts and cloning
junctions were confirmed by DNA sequencing. For -galactosidase activ-
ity assays, triplicate samples from overnight cultures of E. coli strains car-
rying various PZ and control plasmids were grown in Luria-Bertani broth
containing 50 g/ml chloramphenicol and then diluted 1:100 in fresh
broth and grown at 37°C until they reached mid-log phase (optical density
at 600 nm [OD600]  0.6). -Galactosidase expression analysis was per-
formed as described previously (28, 29) with the following modifications.
Cells were diluted in a total volume of 500l Z buffer (60 mM Na2HPO4,
40 mM NaH2PO4 · H2O, 10 mM KCl, 1 mM MgSO4 · 7H2O) followed by
the addition of 50 l of chloroform and 50 l of 0.1% sodium dodecyl
sulfate. The solution was vortexed for 5 s, and the reactions were equili-
brated by incubation at room temperature for 5 min prior to the addition
of 100 l of ortho-nitrophenyl--galactoside (4 mg/ml). The reactions
were stopped by adding 250 l of 1 M Na2CO3 and then centrifuged at
14,000 rpm for 5 min in an Eppendorf microcentrifuge to separate the cell
pellet and the supernatant. The initial OD600 of the cells and the OD420 of
the supernatant were measured and used to calculate -galactosidase ac-
tivity.
Preparation of CEL1 endonuclease extract. CEL1 extract was pre-
pared from celery as described previously (30). Fresh celery stalks (25 kg)
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were washed, chopped to remove the leaves, and juiced to yield approxi-
mately 10 liters of celery juice. Subsequent steps were carried out at 4°C.
Five hundred milliliters of buffer A containing 2 M Tris-HCl (pH 7.7) and
0.1 M phenylmethanesulfonyl fluoride (PMSF) was added to the celery
juice, and the solution was centrifuged to remove plant debris. Protein
was precipitated from the supernatant by ammonium sulfate fraction-
ation in the 25 to 80% saturation range. The protein pellet was resus-
pended in 100 ml buffer B (0.1 M Tris-HCl, pH 7.7, 0.5 M KCl, 100 M
PMSF, 0.01% Triton X-100) and dialyzed overnight against a large vol-
ume of buffer B. The final CEL1 extract was stored in small aliquots at
80°C.
EMS mutagenesis and library construction. Confluent McCoy cells
in a T-75 flask were infected with C. muridarum at an MOI of 0.5. At 16 h
p.i., the culture medium was replaced with 5 ml of DMEM containing 8
g/ml ethyl methanesulfonate (EMS) (Sigma). The cells were exposed to
EMS for 1 h and then washed several times with 1 phosphate-buffered
saline (PBS), after which fresh DMEM without mutagen was added. EB
were bead harvested from the cells at 28 h p.i. and resuspended in 2 ml of
SPG. An IFU assay estimated chlamydial survival after EMS treatment at
less than 0.1% that of the untreated control. Half of the harvest was stored
at80°C, and the remainder was used to infect a fresh T-75 flask of cells.
Four rounds of EMS mutagenesis were performed in total, and the final
harvest yielded 9 105 EB. These EB were divided into small aliquots and
stored at80°C. To construct mutant libraries, 96-well plates of McCoy
cells were infected with 10 EB per well of the mutagenized stock. Mutant
chlamydiae were scaled up by four rounds of passaging in 96-well plates.
Plates from the third passage were stored at80°C to serve as the library.
Genomic DNA was extracted from the final plates by adding 75 l of
alkaline lysis buffer to each well (0.2 mM EDTA, 25 mM NaOH, pH 12.0)
and incubating at 95°C for 10 min, after which the lysis buffer was neu-
tralized by adding an equal volume of 40 mM Tris-HCl (pH 5.0). The
genomic DNA plates were stored at 4°C.
TILLING. Targeting induced local lesions in genomes (TILLING) was
used to identify specific mutants in the library and was performed as
described previously (13). Specific primers (see Table S6 in the supple-
mental material) were used to amplify targeted PZ genes from template
genomic DNA plates, which were extracted from the mutant libraries.
These PCR products were annealed slowly (80°C; 7 s; 60 cycles, decreasing
by 0.3°C every cycle) and then were digested with CEL1 endonuclease.
Digestions were performed for 10 min at 45°C using an empirically deter-
mined volume of CEL1 extract (range, 0.1 to 1 l) diluted in 1 CEL1
buffer (0.01 M MgSO4, 0.01 M HEPES, pH 7.5, 0.02 M KCl, 0.005%
Triton X-100, 2 g/ml bovine serum albumin). The digestions were
stopped by adding 10 l EDTA (0.15 M, pH 8.0). The digested products
were separated on 2% agarose Tris-borate-EDTA (TBE) gels, stained with
Midori Green (Bulldog Bio), and visualized using a ChemiDoc XRS	
device (Bio-Rad Laboratories, Inc., Hercules, CA).
Cytotoxicity assays. McCoy cells seeded on coverslips in 24-well
plates were infected with C. trachomatis, C. muridarum, or cytotoxin mu-
tants at an MOI of 10 or 250 in the presence of 0.1 g/ml rifampin. The
cells were fixed in 3.7% formaldehyde at 3 h p.i. and then permeabilized with
1% Triton X-100. Following staining with Alexa Fluor 488-phalloidin for
visualization of actin filaments, the coverslips were mounted on slides using
ProLong Gold antifade reagent with DAPI (4=,6-diamidino-2-phenylindole)
(Life Technologies). The cells were imaged using a Nikon Eclipse Ni-E fluo-
rescence microscope (Nikon Instruments, Melville, NY).
Lactate dehydrogenase (LDH) assays were performed according to the
manufacturer’s instructions (OPS Diagnostics). McCoy cells were in-
fected with various strains at a range of MOI (10, 25, 100, and 500) in the
presence of rifampin. To determine maximal LDH release, cells in control
wells were lysed with 10% Triton X-100 10 min prior to supernatant
collection. The supernatants were removed from the wells 3 h p.i. after
brief centrifugation of the plates to remove debris. Twenty-five micro-
liters of the supernatants was mixed with 75l of the dye-buffer solution.
The A490 was measured after 15 min incubation at 37°C.
Animal experiments. C57BL/6J mice were obtained from Jackson
Laboratories (Bar Harbor, ME). All animal experiments were approved by
the Institutional Animal Care and Use Committees of the University of
Arkansas for Medical Sciences and Indiana University. Female mice be-
tween 6 and 10 weeks old were treated with 2.5 mg medroxyprogesterone
(Depo-Provera) diluted in 100 l PBS 10 and 3 days prior to infection.
Prior to infectious challenge, the vaginal vault was swabbed to remove
excess mucus. Mice were inoculated vaginally with C. muridarum or PZ
mutants at a concentration of 5  104 IFU in 5 l SPG. The infections
were monitored by enumeration of IFU from cervical swabs collected at
various time points. At 73 days postinfection, the mice were euthanized
and examined visually for hydrosalpinx.
Sequencing library construction and whole-genome sequencing.
Gradient-purified EB were treated with DNase I (NEB) at 37°C for 1 h,
and then 5 mM EDTA was added and the mixtures were incubated at 75°C
for 10 min to halt digestion. Total DNA was extracted using the DNeasy
blood and tissue kit (Qiagen), and DNA concentrations were determined
using the Quant-It high-sensitivity double-stranded DNA (dsDNA) assay
(Life Technologies Corp.) The dsDNA fragments were generated by treat-
ing 1 g of genomic DNA with NEBNext dsDNA Fragmentase (NEB).
DNA sequencing libraries were prepared using the TruSeq Nano DNA
sample preparation kit (Illumina Inc.) according to the manufacturer’s
protocols. Samples were multiplexed using TruSeq Single Index sequenc-
ing primers. Equimolar concentrations of the indexed libraries were com-
bined into a single pool and submitted for Illumina HiSeq sequencing at
the Tufts University Genomics Core Facility. Paired-end 100-bp sequenc-
ing was performed on the Illumina HiSeq 2500 platform.
Genome assembly and sequence analysis. For single nucleotide poly-
morphisms (SNP), nucleotide insertion and deletion (indel) analysis, raw
sequence data were mapped to the corresponding reference genome
(GenBank accession number AE002160.2) using Bowtie2 (56). The result-
ing SAM files were converted to a BAM file format and sorted. SNPs/
indels were called using a Samtools mpileup function. The remaining
ambiguous sequences from the data set and mutation calls with low-
quality scores were resolved by PCR and Sanger sequencing.
Statistics. Data were analyzed using Prism 6.0 software (GraphPad).
For comparisons of multiple groups with more than one variable, two-
way analysis of variance (ANOVA) with Bonferroni posttest was used.
Two-way ANOVA with Bonferroni posttest was also used to analyze the
differences in chlamydial burdens between groups of infected mice. Mul-
tiple comparisons for data with a single variable were analyzed by one-way
ANOVA with Dunnett’s posttest. Differences in the development of
hydrosalpinx between C. muridarum-infected mice and mutant-infected
mice were analyzed by Fisher’s exact test. Differences were considered
statistically significant when the P value was
0.05.
RESULTS
The C. muridarum plasticity zone is transcriptionally active.
The C. muridarum PZ is defined as the 50-kb locus between tc0431
(MACPF) and tc0448 (dsbB) (Fig. 1). The C. muridarum PZ is
poorly characterized, and the only evidence for gene activity in the
region comes from a prior transcriptional study of the cytotoxin
ORFs (tc0437 to tc0439) (19). To determine if and when other PZ
ORFs were expressed, we examined the entire locus for transcrip-
tional activity. RT-PCR analysis of RNA isolated from C. muri-
darum-infected McCoy cells at 24 h p.i. indicated that all the PZ
genes were transcribed (Fig. 2A). Next, we determined the tran-
scriptional and temporal expression profiles of a subset of PZ
ORFs (tc0431 and tc0436 to tc0443) using qRT-PCR analysis at
various time points p.i. The developmentally regulated genes euo,
ompA, and omcB were analyzed as representative chlamydial early,
mid-late, and late genes, respectively (19). Increased expression of
euo was detected by 6 h p.i., whereas ompA transcripts first in-
creased between 6 and 12 h p.i. and de novo omcB expression was
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detected only at 12 h p.i. and did not peak until 18 h p.i. (Fig. 2B).
The expression trend for all of the PZ genes most closely resem-
bled that of euo, and the absolute peak numbers of PZ ORF tran-
scripts were 1 to 3 log units lower than those of ompA and omcB.
Taken together, these results showed that expression of most PZ
ORFs initiates in the early to middle developmental cycle and that
they are expressed at low levels relative to known highly expressed
chlamydial genes.
We next sought to identify the promoters of PZ genes. The
abilities of a series of overlapping cloned fragments of the C. mu-
ridarum PZ to drive expression of a promoterless lacZ gene
were assayed in E. coli to identify promoters. Only two of the
constructs exhibited strong promoter activity. One promoter lo-
cus (nucleotide positions 542868 to 542368 in GenBank
AE002160.2) was located immediately upstream of guaB (see Ta-
ble S5 in the supplemental material) and was in the correct posi-
tion and orientation to drive expression of the putative operon
guaBA-add (4). RT-PCR analysis of guaB, guaA, and add using
primer pairs that amplified across intergenic regions of adjacent
genes confirmed that these genes were cotranscribed (see Fig. S1 in
the supplemental material). A specific primer pair spanning add
and tc0440 also gave rise to an overlapping amplification product
from extracted RNA. However, since these two genes are pre-
dicted to be located on different strands, the RT-PCR product is
likely a result of enzyme run-through. Two putative cytotoxin
genes (tc0437 and tc0438) were found to be in a single transcript
(see Fig. S1 in the supplemental material), but the presence of an
active internal promoter at the 3= end of tc0437 (nucleotide posi-
tions 515330 to 515896) suggested that tc0438 can also be ex-
pressed as a separate transcript (see Table S5 in the supplemental
material). No promoter likely to drive expression of the operons
tc0436-tc0433 and tc0432-tc0431 or the cytotoxin ORFs tc0437 and
tc0439 was identified (see Fig. S1 and Table S5 in the supplemental
material). Failure to identify other promoters for PZ genes whose
expression was confirmed by RT-PCR could indicate that some
PZ promoters were not functional in E. coli or were located out-
side the regions interrogated in the assay.
Members of three PZ gene families are dispensable for C.
muridarum survival and proliferation in vitro. Since little is
known about the potential functions of most PZ ORFs, we next
tested if they were dispensable using a reverse genetic approach.
An EMS-mutagenized C. muridarum library was screened by
TILLING for isolates that had nonsense mutations in any of eight
C. muridarum-specific PZ ORFs: tc0437, tc0438, tc0439, tc0440,
guaA (tc0441), guaB (tc0442), add (tc0443), and MACPF (tc0431)
(13). The TILLING library was constructed with a high mutation
load to facilitate faster screening. To estimate the number of EMS-
induced point mutations in a given gene that would have to be
isolated in order to recover at least one nonsense mutation, we
assumed a Poisson distribution described as follows: P(x 1) 1
 P(x  0)  1  ea, where a  N  p (N is the number of
mutations in gene X that need to be isolated, and p is the proba-
bility of obtaining a nonsense mutation in gene X). The majority
of mutations induced by EMS are GC¡AT transitions. A total of
5 GC transitions in 4 amino acid codons (CAA, CGA, CAG, and
TGG) can yield a stop codon. We use tc0442 as an example to
illustrate how we arrived at an approximation of screen size (N).
The probability p can be calculated as the number of possible
nonsense GC transitions in the analyzed region of tc0442 divided
by the number of GC base pairs in the same region of tc0442 (p
19/585  0.032). For 95% screen saturation, screen size N was
determined as follows: P(x 1) 0.95 1 e0.032N, or n 94.
In other words, if tc0442 is not essential, there is a 95% probability
that at least one of 94 isolated mutants is a nonsense mutant. The
screen sizes for other PZ genes were calculated by the same
method (see Table S7 in the supplemental material).
One or more nonsense mutants in guaBA-add, the C. muri-
darum-specific PZ PLD tc0440, and the cytotoxins (tc0437 to
tc0439) were isolated at the anticipated frequencies, indicating
that these ORFs are not essential for chlamydial survival in vitro.
Despite attaining 95% saturation in our screen for nonsense mu-
tants of tc0431 (MACPF), all of the mutants that we isolated con-
tained either missense or silent mutations (see Table S7 in the
supplemental material). While it is possible that a larger screen of
C. muridarum EMS mutants could have revealed a nonsense mu-
tant, the relatively high frequency at which other PZ nonsense
mutants were obtained argues against this interpretation. Chla-
mydia abortus does not encode MACPF (31, 32), and the Chla-
mydia caviae and human Chlamydia pneumoniae MACPF genes
FIG 1 Map of the C. muridarum PZ and diagram of PZ ORFs. The ORFs are color coded according to function: red, MACPF; green, PLD; yellow, cytotoxin;
orange, purine nucleotide synthesis; gray, conserved hypothetical; blue, peptide ABC transporter; pink, dsbB. The locations of promoters identified by -galac-
tosidase assays in this study are shown by the bent arrows. The genomic locations and nucleotide changes of the nonsense mutations discussed in this study are
indicated in the corresponding ORFs. The diagram is not drawn to scale.
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contain frameshifts (5, 32, 33), so our result could indicate that
MACPF plays an essential, species-specific role in C. muridarum.
PZ mutants display mild in vitro growth defects. The PZ
nonsense mutants were initially characterized using temporal re-
coverable IFU assays. Since multiple independent mutants of
tc0440 and guaA were recovered by TILLING, we selected a rep-
resentative mutant of each with a nonsense mutation located clos-
est to the predicted 5= end of these ORFs for further analysis. The
growth kinetics of most of the PZ mutants paralleled those of C.
muridarum, with the exception of add and guaB, which attained
maximal EB production at 18 h p.i. as opposed to 30 h p.i. None of
the mutants exhibited dramatic growth defects, although the IFU
production of most of the mutants was significantly reduced com-
pared to that of C. muridarum (Fig. 3). This modest reduction in
IFU yield could be caused either by mutations in the PZ or by
background mutations in the strains. Confocal microscopy failed
to reveal obvious differences between the morphology of the mu-
tant and C. muridarum inclusions (data not shown). These results
implied that the presence of nonsense mutations in PZ ORFs did
not hinder the ability of C. muridarum to form inclusions, com-
plete development, or produce infectious EB.
The cytotoxicity of cytotoxin nonsense mutants is reduced.
Since none of the PZ mutants displayed pronounced growth or
morphological defects, we focused on examining phenotypes that
FIG 2 Transcription of C. muridarum PZ ORFs initiates in the early to middle phase of the developmental cycle. Total RNA was isolated from C. muridarum-
infected McCoy cells at 0, 6, 12, 18, 24, and 30 h p.i. (A) RT-PCR at 24 h p.i. indicated that all genes in the PZ are transcribed. Whether amplification was
performed with (	) or without () reverse transcriptase is indicated. (B) The kinetics of transcription of select PZ ORFs was characterized by qRT-PCR.
Transcript levels were normalized to standard curves of dilutions of C. muridarum chromosomes. The data represent the mean transcript levels with standard
deviations (SD) from three independent experiments. euo, ompA, and omcB represent early, mid-late, and late genes, respectively.
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have been indirectly attributed to the chlamydial cytotoxins in
previous studies. The C. muridarum LCT-like cytotoxins are pur-
ported to mediate multiplication-independent cytopathic effects
of C. muridarum EB on host cells at high MOI (19). This phenom-
enon, referred to as “immediate cytotoxicity” (34), resembles the
cytoskeletal collapse observed in cultured cells treated with clos-
tridial TcdB (19).
To determine if the C. muridarum cytotoxin gene (tc0437,
tc0438, and tc0439) nonsense mutants were less cytotoxic, HeLa
cells were infected with EB at an MOI of 250 in the presence of
rifampin to block chlamydial multiplication. The cells were fixed
and stained with phalloidin at 3 h p.i. and examined by fluores-
cence microscopy. HeLa cells infected with C. trachomatis serovar
L2 strain 434/Bu (C. trachomatis), a cytotoxin-negative strain, did
not differ in morphology from uninfected cells. In contrast, cell
rounding and alterations in actin filament morphology were ob-
served in infections with C. muridarum and the cytotoxin mutants
(Fig. 4 A). This implied that the single cytotoxin mutants retained
some cytotoxic activity.
Microscopy could not distinguish small variations in cytotox-
icity, so we measured LDH release at 3 h p.i. from cells infected
with C. muridarum, C. trachomatis, and the mutants at various
MOI. As expected, C. trachomatis elicited minimal LDH release
even at an MOI of 500. In contrast, C. muridarum caused cells to
release significantly more LDH at high MOI. Interestingly, the
tc0437 and tc0439 mutants elicited lower LDH release than C.
muridarum at the highest MOI tested (Fig. 4B). This could indi-
cate that tc0437 and tc0439 wild-type alleles encode active toxins
or, alternatively, that background mutations in the mutant strains
affected EB cytotoxic activity. Undiminished cytotoxicity of the
tc0438 mutant implies that TC0438 may not be functional or has
an unrelated function.
IFN- resistance is unaltered in C. muridarum PZ mutants.
While high-multiplicity infections were important in associating a
toxin-like activity with chlamydial EB, these doses may not be
relevant in natural chlamydial disease. Roles for the chlamydial
cytotoxins in host cell attachment and entry, vesicle trafficking,
FIG 3 C. muridarum PZ mutants exhibit mild growth defects. rIFU analysis
was performed for C. muridarum (CM) and PZ mutants at various time inter-
vals following infection of McCoy cells. The data shown are from experiments
performed in parallel. The data represent the average (	SD) ratios of input to
output IFU from three independent experiments performed in triplicate. ****,
P
 0.0001; ***, P
 0.001; **, P
 0.01 by two-way ANOVA with Bonferroni
post hoc test.
FIG 4 tc0437 and tc0439 mutants have reduced cytotoxicity. (A) HeLa cells were infected at an MOI of 250 in the presence of rifampin and were fixed 3 h p.i. Cell
morphology and actin structure were visualized by staining with Alexa Fluor 488-phalloidin (green) and DAPI (blue). Overlays of fluorescence micrographs of
cells that were mock infected or infected with C. muridarum (CM), C. trachomatis (CTL), tc0437, tc0438, or tc0439 are depicted. The images are representative of
the results of three independent experiments. (B) LDH in supernatants of HeLa cells infected at various MOI in the presence of rifampin. Shown are C.
muridarum (black), C. trachomatis (gray), tc0437 (hatched), tc0438 (white), and tc0439 (crosshatched). Triton X-100-treated cells were used as positive controls
for LDH release. The data show the mean percentages (	SD) of the positive control from three independent experiments performed in triplicate. ****, P 

0.0001; **, P
 0.01 by one-way ANOVA with Dunnett’s post hoc test.
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and modification of host cell GTPases have been reported (35–
37). The C. muridarum cytotoxins have also been proposed to
mediate evasion of the inhibitory effects of IFN- responses in
murine cells (12). To test the latter hypothesis, McCoy cells were
treated with IFN-, followed by infection with C. trachomatis, C.
muridarum, or cytotoxin mutants. At 24 h, inclusions were either
directly counted (Fig. 5A) or harvested for enumeration of viable
EB contained by the inclusions using IFU assays (Fig. 5B). C. tra-
chomatis, but not C. muridarum, was dramatically inhibited by
IFN-. IFN- treatment did not significantly affect the survival or
infectivity of the cytotoxin mutants compared to C. muridarum.
Parallel experiments with other PZ nonsense mutants indicated
that they were also similarly resistant to IFN- (Fig. 5). Thus,
disruption of individual cytotoxin or other PZ ORFs did not con-
fer IFN- sensitivity to C. muridarum.
PZmutants retain virulence in themouse genital tract infec-
tionmodel. Intravaginal inoculations of mice with human C. tra-
chomatis isolates result in mild infections of short duration with
minimal upper genital tract infection and pathology (38). In com-
parison, C. muridarum is more virulent in this model, and the
postinfection sequelae mimic human disease (39). To determine if
the C. muridarum PZ genes were niche-specific virulence factors
in mice, PZ mutants were analyzed in the murine genital tract
infection model. The chlamydial burden in mice infected with the
tc0439 cytotoxin mutant was significantly lower at 3 days postin-
fection than in animals infected with C. muridarum. Infection
trajectories in mice inoculated with the tc0437 and tc0438 mutants
also trended lower during the first week of infection. However,
chlamydial recoveries of all three cytotoxin mutants appeared
identical to C. muridarum infection at later time points (Fig. 6A).
We also did not observe any significant deviation in bacterial loads
of mice infected with the tc0440 mutant compared to mice in-
fected with C. muridarum (Fig. 6B). Interestingly, the guaA non-
sense mutant behaved identically to C. muridarum, whereas guaB
and add mutants displayed reduced pathogen burdens at early
data points (Fig. 6C and D). The guaBA-add operon putatively
encodes products that function in the same purine-biosynthetic
pathway. The absence of bacterial-shedding phenotypes in the
guaA mutant suggested either that the phenotypes of the guaB and
add mutants were due to background mutations or that guaBA-
add acts noncanonically in C. muridarum. Since none of the PZ
mutants were completely attenuated in vivo, we conclude that
these genes are dispensable for infection of the murine genital
tract.
Infected mice were also scored at 73 days postinfection for the
presence of hydrosalpinx, an immunopathological consequence
of chlamydia genital infection. Eighty percent (24/30) of the mice
infected with C. muridarum developed hydrosalpinx compared to
63% (10/16) of guaA, 63% (5/8) of guaB, 13% (1/8) of add, 75%
(9/12) of pld, 38% (3/8) of tc0437, 50% (4/8) of tc0438, and 38%
(3/8) of tc0439 mutant-infected mice. The development of hydro-
salpinx was significantly lower in add, tc0437, and tc0439 mutant-
infected mice (P
 0.001, P 0.03, and P 0.03, respectively). It
should be noted, however, that the differences observed in hydro-
salpinx cannot necessarily be attributed to specific PZ gene muta-
tions due to other background mutations found in the mutants.
PZ mutants contain multiple background mutations. To
identify a plausible explanation for the differing phenotypes of the
purine pathway mutants, we sequenced the genomes of the parent
strain and PZ mutants to an average coverage of 2,075 on the
Illumina HiSeq platform (Table 1; see Tables S8 to S14 in the
supplemental material). Comparison to published C. muridarum
genomes indicated that our parent most closely resembled a C.
muridarum Weiss isolate that was recently sequenced by K. H.
Ramsey et al. (Table 1). On average, the PZ mutants contained
36.4 mutations, 66.67% of which were nonsynonymous substitu-
tions. Most (98.43%) of the mutations were GC¡AT transitions,
consistent with EMS-induced changes. Several synonymous and
nonsynonymous mutations were shared by some PZ mutant
strains, which was a consequence of our serial mutagenesis strat-
egy. They included mutations in recA, alaS, tc0237, tc0283, tc0471,
tc0490, rpoC, aroA, upp, and tc0877 that were common to the add,
tc0437, and tc0438 mutants. The add and tc0437 mutant strains
contained identical mutations in tc0035, tc0069, tc0438, tc0575,
tc0917, and pfkA-2. The tc0438 mutant shared mutations in murB,
tc0330, and tc0575 with the add mutant and a pmpB–pmpC-2 mu-
tation with the tc0437 mutant. Finally, mutations in tc0054,
tc0191, pmpD, tc0250, tc0290, tc0312, tc0600, and an intergenic
region (GenBank genome position 126188) were present in the
tc0439 and guaB mutants. Interestingly, multiple mutant strains
had nonsense mutations in tc0412, an ortholog of C. trachomatis
ct135 that has been linked to virulence of C. trachomatis in the
murine genital tract model (40). None of the tc0412 mutants ex-
cept add were significantly attenuated in the murine GT, and an
identical stop mutation was present in the tc0437 mutant strain,
suggesting that attenuation of the add mutant was not linked to
this tc0412 allele. No common mutations were present in the guaB
and add mutants, which is consistent with the hypothesis that
FIG 5 PZ mutants are resistant to IFN-. The sensitivity to IFN- treatment
of C. muridarum (CM), C. trachomatis (CTL), and various PZ mutants was
assessed by IFU assay (A) and rIFU assay (B). The data are represented as the
average (	SD) percentages of untreated (no IFN-) infected controls from
three independent experiments performed in triplicate. ***, P
 0.001; **, P

0.01 by one-way ANOVA with Dunnett’s post hoc test.
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guaB and add might function in a noncanonical pathway indepen-
dently of guaA.
DISCUSSION
C. muridarum and C. trachomatis are genetically closely related,
and genital infections of their respective hosts, mice and humans,
have many similarities (4, 41). While T-cell immunity is critical
for the resolution of chlamydial infection in both mice and hu-
mans, other aspects of immunity, most notably IFN- responses,
appear to differ and are incompletely characterized (38). The re-
sults of our study suggest that although the PZ is the site of max-
imal divergence between the genomes of these pathogens, C. mu-
ridarum IFN- resistance determinants may not localize to the
region.
We show that most PZ ORFs are transcribed in the early to
middle phase of the developmental cycle and are expressed at rel-
atively low levels. Although we identified two promoter regions
that support our RT-PCR findings and that could provide plausi-
ble explanations for how some PZ ORFs are transcribed, strong
promoters that could drive expression of one of the cytotoxin
ORFs (tc0437) and an adjacent operon of PZ PLD (tc0436 to
tc0432) that is relatively conserved in Chlamydia spp. were not
identified. The putative start sites of tc0436 and tc0437 are located
less than 1,000 bp apart in opposite strands of the C. muridarum
genome, so perhaps our chosen cloning site disrupted two pro-
moters in the same narrow region on opposing strands, thus com-
promising their detection. Another possibility is that E. coli sigma
factors cannot recognize the chlamydial promoters in this region.
For example, the auxiliary C. trachomatis transcription factor
GrgA, which is not conserved in E. coli, directs expression from
some chlamydial 66-dependent promoters (42). Chlamydial 28
also cannot complement an E. coli 28 mutant, indicating that
even conserved E. coli and chlamydial sigma factors are not com-
pletely interchangeable (43). We attempted to identify additional
promoters using transcriptome sequencing (RNA-seq), but low
expression of PZ ORFs relative to other, highly expressed genes
yielded insufficient coverage for mapping transcriptional start
sites in this region. As costs of deep RNA-seq decrease further and
methods for enrichment of chlamydial transcripts from host cell
transcripts improve, it might make sense to revisit this approach
in the future. Better understanding of transcriptional organiza-
tion could inform subsequent attempts to inactivate PZ operons.
Two of three cytotoxin mutants displayed reduced cytotoxicity
in vitro, which suggests that these alleles are functional. We hope
FIG 6 Mouse genital tract infections with C. muridarum PZ mutants. Groups of mice were challenged intravaginally with 50,000 IFU of C. muridarum (CM) or
various PZ mutants. The infection curve for C. muridarum-infected mice (n 30) is reproduced in each panel for comparison. (A) Lower genital tract shedding
of IFU by mice infected with C. muridarum differed significantly from that by mice infected with the tc0439 mutant (n 8) at day 3 postinfection (P
 0.01), but
not that by mice infected with tc0437 (n 8) or tc0438 (n 8). (B and C) IFU shedding from mice infected with CM did not vary significantly from that from
mice infected with the t0440 (n 12) (B) or guaA (n 16) mutant (C). (D) Shedding by mice infected with the add (n 8) mutant was significantly less than
shedding by mice infected with C. muridarum at 3 days (P
 0.0001) and 7 days (P
 0.01) postinfection. IFU shedding from mice infected with the add (n
8) mutant was also significantly reduced at 3 days (P
 0.0001), 7 days (P
 0.05), and 10 days (P
 0.001) postinfection. The data are presented as mean numbers
of IFU (	SD) for the mice in each group. Statistical differences were analyzed by two-way ANOVA with Bonferroni post hoc test.
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to verify this in future experiments using allelic complementation
or by utilizing isogenic cytotoxin mutant strains. The biological
role of chlamydial cytotoxins is still largely a matter of speculation.
Polymorphisms in the cytotoxins have been associated with dif-
ferences in the ocular and genital tropisms of C. trachomatis iso-
lates (20). On the basis of their homology to LCTs and YopT, we
have previously proposed that the cytotoxins may inactivate in-
terferon-regulated GTPases that inhibit C. trachomatis, but not C.
muridarum, in IFN--treated mouse cells (44). Finally, mutants of
E. coli efa1, another chlamydial cytotoxin gene homolog, exhibit
reduced adherence to epithelial cells and fail to colonize colonic
tissue effectively in mice (45). The observed trend toward a lower
chlamydial burden during the first week of infection in mice in-
oculated with the chlamydial cytotoxin mutants could indicate
similar roles for C. muridarum cytotoxins in adhesion and colo-
nization, but this hypothesis requires experimental validation. An
additional future direction would be to evaluate the IFN- resis-
tance and virulence of double and triple cytotoxin mutants.
One of the most surprising findings of our study was that the
guaB (IMP dehydrogenase) and add (adenosine deaminase) mu-
tants were moderately attenuated in the GT while a guaA (GMP
synthase) mutant was not. Genome sequencing confirmed that
the phenotypes of the guaB and add mutants were not caused by a
common background mutation. Thus, if unrelated background
mutations were not responsible for the very similar GT pheno-
types, our results suggest C. muridarum could encode an addi-
tional cryptic GMP synthase enzyme or that C. muridarum purine
salvage acts noncanonically. The guaBA-add cluster has been re-
tained by several chlamydial species, including those that cause
respiratory illness, such as Chlamydia psittaci, Chlamydia felis, and
human isolates of C. pneumoniae, but it is unknown if they are
functional (33, 46, 47). guaA and guaB are known virulence deter-
TABLE 1 Comparison of the genome of the wild-type C. muridarum isolate used in this study to those of other C. muridarum reference strains
Gene ID Description Position
Base
C. muridarum used
in study
C. muridarum
Nigga
C. muridarum
Weissb
tc0007 Exodeoxyribonuclease V, beta chain, putative 10505 A
10558 A,C
10564 A
tc0027 Conserved hypothetical protein 32915 G
tc0052 Major outer membrane protein, porin; OmpA 58882 T
58904 T
59065 C C T
tc0107 Lipoprotein 126406 G G
126416 A
None Intergenic 126383 G
126436 A
126475 A
tc0124 Transcription repair-coupling factor; TrcF 151212 T T
tc_r05 rRNA-23S rRNA 158800 G
tc0138 Phospho-N-acetylmuramoylpentapeptide transferase;
MraY
169451 TTTT T T
tc0168 Ribosomal protein L34; RpmH 200671 C G C
tc0301 Methionyl tRNA synthetase; MetG 358414 T
tc0338 ABC transporter, periplasmic substrate binding protein 401302 G
tc0341 ABC transporter, permease protein 403623 T
403624 C A A
403626 C
403652 C,G T C
403714 G
tc0342 ABC transporter, permease protein 404473 T
404884 A A
tc0343 1-Deoxy-D-xylulose 5-phosphate reductoisomerase; Dxr 405819 G
tc0359 Hypothetical protein 419119 C
tc0408 Hypothetical protein 468932 T G T
tc0412 Hypothetical protein 473118 A A
tc0437 Adherence factor 515204 A C C
tc0493 Phenylacrylic acid decarboxylase; UbiX 600435 A C C
tc0708 Translation elongation factor; Tuf 712587 C
Hypothetical protein 846475 G G
tc0727 Outer membrane protein; OmcB 866121 T G T
tc0832 DNA polymerase III alpha subunit; DnaE 967487 A A
tc0879 Hypothetical protein 1022529 A
1022551 A
tc0893 groEL-2 1035913 A
a C. muridarum Nigg isolate accession number: AE002160.2.
b C. muridarum Weiss isolate accession number: ACOW00000000.
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minants in other pathogenic organisms, like Borrelia burgdorferi
and Francisella tularensis, during intraperitoneal and subcutane-
ous infection of mice, indicating that one or more purine nucleo-
side monophosphates (NMP) are limiting in certain mammalian
niches (48, 49). Thus, an explanation of our results could be that
NMP levels in the murine GT are sufficient to support chlamydial
growth, whereas other tissues, like the lung, are starved for purine
nucleotides. We hope to differentiate these possibilities by con-
structing additional guaA, guaB, and add nonsense mutants and
comparing their virulence in murine GT and lung infection mod-
els.
Although we were unable to identify a role for individual PZ
genes in IFN- resistance and murine genital infection, functional
redundancy in the cytotoxin and PLD superfamily of proteins
could have masked the effects of the loss of a single family mem-
ber. However, our data suggest that cytotoxin functions are not
wholly redundant, and true functional redundancy of these alleles
is not consistent with the relatively low amino acid identity to one
another (40 to 42%). While it would be possible to disrupt all
members of the cytotoxin family and the guaBA-add operon se-
quentially, variable alleles, including tc0412, are a practical imped-
iment to constructing isogenic strains by iterative TILLING (40,
50). Another possible explanation for the lack of phenotype of
select PZ mutants is the emergence of suppressor mutations. Al-
though this possibility is difficult to exclude, the fact that all of the
PZ mutants were isolated from pools of mutants at the expected
frequencies indicates that it is unlikely to have been a significant
issue. We are currently investigating the possibility of disrupting
the MACPF-PZ PLD (tc0432-tc0431; tc0436 to tc0433), cytotoxin
(tc0437-tc0438), and guaBA-add operons using polar transposon
insertions by the Targetron method developed by Johnson and
Fisher (51).
In summary, our results imply that all the examined PZ ORFs
are nonessential for virulence in the mouse GT. However, we can-
not rule out their importance in other niches. C. muridarum was
originally isolated from the lungs of symptom-free laboratory
mice. Disease was observed only upon inoculation of mice with
serially passaged lung homogenates, indicating that very low levels
of C. muridarum are typically present in pulmonary tissue (52).
Later studies demonstrated that C. muridarum is transmitted
through the oral-fecal route, which suggests that the gut is a res-
ervoir and that small numbers of C. muridarum organisms enter
the lungs during feeding (53). Finally, it is notable that guaBA-add
and cytotoxin homologs of other intracellular pathogens modu-
late infections of the lung and gastrointestinal tract, respectively
(45, 48, 54, 55). Thus, examination of C. muridarum PZ mutants
in lung or gastrointestinal tract models of mouse infections is
warranted. A positive implication of our study is that successful
modeling of human disease in the murine GT does not appear to
require much of the C. muridarum PZ. Future investigations of
polymorphisms outside the PZ will be important in the identifi-
cation of C. muridarum alleles that confer IFN- resistance and
dictate virulence in the murine GT model.
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